Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 39

Sort by

Sort Order Select

Journal Articles

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study

Alexander Röth, Wilma Barcellini, Shirley D'Sa, Yoshitaka Miyakawa, Catherine M Broome, Marc Michel, David J. Kuter, Bernd Jilma, Tor Henrik Anderson Tvedt, Stella Lin, Xiaoyu Jiang, Caroline Reuter, William Hobbs, Sigbjørn Berentsen

Blood (2019) 134 (Supplement_2): LBA-2.

https://doi.org/10.1182/blood-2019-132490

Published: 2019

Journal Articles

Impact of Co-Morbidities on Outcome in a Predominantly Hispanic Population of Hodgkin and Non-Hodgkin Lymphoma Patients

Michelle Janania Martinez, MD, Juan F Garza, MD, Tyler W Snedden, MD, Prathibha Surapaneni, MD, Snegha Ananth, MBBS, Jeremy Rawlings, MD, David J Gregorio, DO, Sushanth Kakarla, MD, Qianqian Liu, PhD, Joel E Michalek, PhD, Adolfo Enrique Diaz, MD

Blood (2019) 134 (Supplement_1): 2204.

https://doi.org/10.1182/blood-2019-129442

Published: 2019

Journal Articles

Beliefs and Practices Among Adults with Sickle Cell Disease Regarding Reproductive Health Decisions and Family Planning

Laura Ibidunni, Kristin Paulyson Nunez, MS, CGC, Jude C Jonassaint, RN, Laura De Castro, MD MHSc

Blood (2019) 134 (Supplement_1): 2101.

https://doi.org/10.1182/blood-2019-122255

Published: 2019

Journal Articles

Regional Differences in the Beliefs and Practices Among Adults with Sickle Cell Disease Regarding Reproductive Health and Family Planning: A Sub-Analysis

Laura Ibidunni, Kristin Paulyson Nunez, MS, CGC, Jude C Jonassaint, RN, Laura De Castro, MD MHSc

Blood (2019) 134 (Supplement_1): 2114.

https://doi.org/10.1182/blood-2019-129554

Published: 2019

Journal Articles

Myeloproliferative Neoplasm (MPN) Patient Online Questionnaire: Assessing Patients' Disease Knowledge in a Rare Hematologic Malignancy in the Modern Digital Information Era

Naveen Pemmaraju, MD, Theresa Clementi, Wei Qiao, PhD, Susan K Peterson, PhD, Vicky Zoeller, Andrew J. Schorr, Srdan Verstovsek, MD PhD

Blood (2019) 134 (Supplement_1): 1670.

https://doi.org/10.1182/blood-2019-129545

Published: 2019

Journal Articles

CML Patients' Views on Psychological Support throughout the Treatment-Free Remission Journey

Giora Sharf, Andreas Hochhaus, MD, Jan Geissler, Celia Marin, Zack Pemberton-Whiteley, Felice Bombaci, Rita I O Christensen, Bahija Gouimi, Mina Daban, Nigel B Deekes, Jennie Bradley

Blood (2019) 134 (Supplement_1): 2934.

https://doi.org/10.1182/blood-2019-123942

Published: 2019

Journal Articles

Diffuse Large B Cell Lymphoma (DLBCL) Experience in a Majority-Minority Community: The UT Health San Antonio Story

Daniela Hernandez, MD, Michelle Janania Martinez, MD, Juan F Garza, MD, Tyler W Snedden, MD, Adolfo E Diaz, MD

Blood (2019) 134 (Supplement_1): 2916.

https://doi.org/10.1182/blood-2019-127485

Published: 2019

Journal Articles

Barriers to Care Amongst Patients with Inherited Bleeding Disorders: Results from Two Nation-Wide Canadian Surveys

Sumedha Arya, MD BSc, Pamela Wilton, RN, CRE, David Page, Laurence Boma-Fischer, PT, MSc, Georgina Floros, RN, Katie Dainty, PhD, Rochelle Winikoff, MD FRCPC, Michelle Sholzberg, MDBSc,FRCPC,MSc

Blood (2019) 134 (Supplement_1): 4704.

https://doi.org/10.1182/blood-2019-126288

Published: 2019

Journal Articles

Inhibition of the Classical Pathway of Complement with Sutimlimab in Chronic Immune Thrombocytopenic Purpura Patients without Adequate Response to Two or More Prior Therapies

Catherine M Broome, MD, Alexander Röth, MD PhD, David J. Kuter, Marie Scully, Roy Smith, Jennifer Wang, Caroline Reuter, William Hobbs

Blood (2019) 134 (Supplement_1): 898.

https://doi.org/10.1182/blood-2019-122210

Published: 2019

Journal Articles

Hodgkin Lymphoma Outcomes: Can We Expect Ethnic Parity in a Hispanic Prevalent Population?

Michelle Janania Martinez, MD, Prathibha Surapaneni, MD, Juan F Garza, MD, Tyler W Snedden, MD, Snegha Ananth, MBBS, Jeremy Rawlings, MD, David J Gregorio, DO, Sushanth Kakarla, MD, Qianqian Liu, PhD, Joel E Michalek, PhD, Adolfo Enrique Diaz, MD

Blood (2019) 134 (Supplement_1): 4056.

https://doi.org/10.1182/blood-2019-129058

Published: 2019

Journal Articles

Differing Perceptions between Myelodysplastic Syndrome (MDS) Patients and Providers Regarding Blood Transfusions

David J. King, BS, Martina C. Murphy, MD, Rodney A. Schmidt, PhD, Matthew Lesser, MS, Alice Houk, MPS, Ellen Salkeld, PhD, Christopher R. Cogle, MD

Blood (2019) 134 (Supplement_1): 5418.

https://doi.org/10.1182/blood-2019-123474

Published: 2019

Journal Articles

Social Media Network Utility in Disease Education: Experience from a CML-Disease Awareness Medical Education Program

Ehab L. Atallah, MD, Vamsi Kota, MBBS, Islam Sadek, Andrea Damon, PhD, Ji-May Jen, PharmD, Berna Cakmak, BPharm, Joshua Landy, MD FRCPC, Sharon Vorona, MBBS, Jerald P. Radich, MD

Blood (2019) 134 (Supplement_1): 5842.

https://doi.org/10.1182/blood-2019-124809

Published: 2019

Journal Articles

Assessing Patient-Reported Outcomes in People with Myelodysplastic Syndromes: Can a Customized Selection of Items from the EORTC Library Enhance the EORTC QLQ-C30?

Jill A Bell, PhD, Farrah A Pompilus, Anna Christian, MPH, Flora Mazerolle, MSc, Fatima Scipione, Rafael Bejar, MD PhD, Aaron Galaznik, PhD, Robert J. Fram, MD, Douglas V. Faller, MD PhD, Stefan Cano, PhD CPsychol, AFBPsS, Antoine Regnault, PhD

Blood (2018) 132 (Supplement 1): 4856.

https://doi.org/10.1182/blood-2018-99-116977

Published: 2018

Journal Articles

Addressing Challenges in Living with AML: Impact of Video-Based Patient Education on Knowledge and Behavior

Anne C Roc, PhD, David P. Steensma, MD, Michelle Rajotte, Wendy Turell, DrPH

Blood (2018) 132 (Supplement 1): 4872.

https://doi.org/10.1182/blood-2018-99-120328

Published: 2018

Journal Articles

Treatment in AML and MDS Patients Who Are Ineligible for Intensive Chemotherapy: Using Social Media Intelligence to Capture What Really Matters to Patients

Alison Booth, MSc, Timothy J Bell, Sonia Halhol, MSc, Shiyu Pan, MSc, Verna L Welch, PhD MPH, CPEHR, CPHIMS, Evie Merinopoulou, MSc, Dimitra Lambrelli, PhD, Andrew Cox, PhD

Blood (2018) 132 (Supplement 1): 4826.

https://doi.org/10.1182/blood-2018-99-112827

Published: 2018

Journal Articles

Correlation of Lymphoma Patient Information Level with Healthcare Experience

Natalie Dren, BSc, MPH, Lorna Warwick, Karen Van Rassel, Theodoros Moysiadis, Christina Karamanidou, MSc, Dip.Hyp., PhD, Aliki Xochelli, MD PhD

Blood (2018) 132 (Supplement 1): 4782.

https://doi.org/10.1182/blood-2018-99-115392

Published: 2018

Journal Articles

Patients' Perspectives on the Definition of Cure in Chronic Myeloid Leukemia: A US Based Survey

Blood (2018) 132 (Supplement 1): 5843.

https://doi.org/10.1182/blood-2018-99-114589

Published: 2018

Journal Articles

Using Social Media to Highlight Unmet Needs in Patients with AML and MDS Ineligible for Intensive Chemotherapy: A Patient Centered Perspective

Alison Booth, MSc, Timothy J Bell, Sonia Halhol, MSc, Shiyu Pan, MSc, Verna L Welch, PhD MPH, CPEHR, CPHIMS, Evie Merinopoulou, MSc, Dimitra Lambrelli, PhD, Andrew Cox, PhD

Blood (2018) 132 (Supplement 1): 4831.

https://doi.org/10.1182/blood-2018-99-112922

Published: 2018

Journal Articles

Follow-up and Treatment Expectancy and Compliance of Y-Generation Hemophiliacs

Bulent Zulfikar, Prof, Basak Koc, MD, Yusuf Buyukpinarbasili, Fikret Bezgal, Caner Dadak, Funda Ciga, Irmak Gumustas, Haluk Zulfikar

Blood (2018) 132 (Supplement 1): 5029.

https://doi.org/10.1182/blood-2018-99-117901

Published: 2018

Journal Articles

Patient-Centered Insights on Living with Acute Myeloid Leukemia and Its Treatments Using Patient Reported Information Shared Via Social Media

Sigrid Rebecca Crawford, MA, Timothy J Bell, Rebecca Rushton, MSc, Lynda Doward, MRes

Blood (2018) 132 (Supplement 1): 5907.

https://doi.org/10.1182/blood-2018-99-112427

Published: 2018

NARROW

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study

Impact of Co-Morbidities on Outcome in a Predominantly Hispanic Population of Hodgkin and Non-Hodgkin Lymphoma Patients

Beliefs and Practices Among Adults with Sickle Cell Disease Regarding Reproductive Health Decisions and Family Planning

Regional Differences in the Beliefs and Practices Among Adults with Sickle Cell Disease Regarding Reproductive Health and Family Planning: A Sub-Analysis

Myeloproliferative Neoplasm (MPN) Patient Online Questionnaire: Assessing Patients' Disease Knowledge in a Rare Hematologic Malignancy in the Modern Digital Information Era

CML Patients' Views on Psychological Support throughout the Treatment-Free Remission Journey

Diffuse Large B Cell Lymphoma (DLBCL) Experience in a Majority-Minority Community: The UT Health San Antonio Story

Barriers to Care Amongst Patients with Inherited Bleeding Disorders: Results from Two Nation-Wide Canadian Surveys

Inhibition of the Classical Pathway of Complement with Sutimlimab in Chronic Immune Thrombocytopenic Purpura Patients without Adequate Response to Two or More Prior Therapies

Hodgkin Lymphoma Outcomes: Can We Expect Ethnic Parity in a Hispanic Prevalent Population?

Differing Perceptions between Myelodysplastic Syndrome (MDS) Patients and Providers Regarding Blood Transfusions

Social Media Network Utility in Disease Education: Experience from a CML-Disease Awareness Medical Education Program

Assessing Patient-Reported Outcomes in People with Myelodysplastic Syndromes: Can a Customized Selection of Items from the EORTC Library Enhance the EORTC QLQ-C30?

Addressing Challenges in Living with AML: Impact of Video-Based Patient Education on Knowledge and Behavior

Treatment in AML and MDS Patients Who Are Ineligible for Intensive Chemotherapy: Using Social Media Intelligence to Capture What Really Matters to Patients

Correlation of Lymphoma Patient Information Level with Healthcare Experience

Patients' Perspectives on the Definition of Cure in Chronic Myeloid Leukemia: A US Based Survey

Using Social Media to Highlight Unmet Needs in Patients with AML and MDS Ineligible for Intensive Chemotherapy: A Patient Centered Perspective

Follow-up and Treatment Expectancy and Compliance of Y-Generation Hemophiliacs

Patient-Centered Insights on Living with Acute Myeloid Leukemia and Its Treatments Using Patient Reported Information Shared Via Social Media

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only